ORP 101

Drug Profile

ORP 101

Alternative Names: Buprenorphine dimer - OrphoMed; ORP-101

Latest Information Update: 06 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator OrphoMed
  • Class Cyclopropanes; Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid kappa receptor antagonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Irritable bowel syndrome

Most Recent Events

  • 06 Jun 2017 Pharmacokinetics and pharmacodynamics data from a preclinical study in Irritable bowel syndrome released by OrphoMed
  • 23 May 2017 Preclinical trials in Irritable bowel syndrome in USA (IV)
  • 23 May 2017 Preclinical trials in Irritable bowel syndrome in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top